Track 2 - Turbocharging Innovation in CMC: Driving Back to Rational Drug Design

(M1030-01-03) Monodisperse Fully Porous Particles (MFPP) for Use in Increasing Resolution in Liquid Chromatography

(T1030-01-08) Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity

(T1030-01-09) Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors

(M1130-01-01) An Adjuvanted Microparticulate Microneedle-Based Gonorrhea Vaccine Induced a Robust Immune Response in Mice

(T1130-01-05) CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism

(M1130-01-06) Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment

(M1330-01-03) FM1000 Surfactant is Compatible with Downstream Bioprocessing

(T1430-01-02) Preparation of PEG-b-PLA Nanoparticles via Inline Sonication for Controlled Release Applications

(M1430-01-04) Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension

(T1430-01-07) Importance of Quality Control of In Vitro Transcribed RNA

(T1430-01-08) Sensitization of Paclitaxel-Induced Apoptosis by Echinops giganteus Extract via Downregulation of PI3K/Akt/NF-κB Pathway and Enrichment of TIMP-3 in Cervical Cancer